Skip to results
Modify your search
NARROW
1-5 of 5
Authors: Mauro Chiarito
Sort by
Journal Article
Efficacy and safety of P2Y12 inhibitor monotherapy after complex PCI: a collaborative systematic review and meta-analysis Free
Johny Nicolas and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 3, April 2023, Pages 240–250, https://doi.org/10.1093/ehjcvp/pvac071
Published: 23 December 2022
Journal Article
Perioperative management of P2Y12 inhibitors in patients undergoing cardiac surgery within 1 year of PCI Free
Davide Cao and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 8, December 2022, Pages 796–805, https://doi.org/10.1093/ehjcvp/pvac024
Published: 07 April 2022
Journal Article
EDITOR'S CHOICE
SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis Free
Victor Razuk and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 6, October 2022, Pages 557–567, https://doi.org/10.1093/ehjcvp/pvac001
Published: 11 January 2022
Journal Article
Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis Free
Anne H Tavenier and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 5, September 2022, Pages 492–502, https://doi.org/10.1093/ehjcvp/pvab068
Published: 30 August 2021
Journal Article
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality Free
Francesco Cannata and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 6, November 2020, Pages 412–414, https://doi.org/10.1093/ehjcvp/pvaa056
Published: 05 June 2020
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals